B Bernstein
Overview
Explore the profile of B Bernstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
555
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Badri P, Dutta S, Coakley E, Cohen D, Ding B, Podsadecki T, et al.
Am J Transplant
. 2015 Feb;
15(5):1313-22.
PMID: 25708713
ABT-450, ombitasvir, and dasabuvir are direct-acting antiviral agents (DAAs) that have been developed for combination treatment of chronic hepatitis C virus (HCV) infection. Because these DAAs have metabolic and transporter...
2.
Bernstein B
IEEE Eng Med Biol Mag
. 2009 Jun;
3(2):36-8.
PMID: 19493745
The pacemaker is celebrated as an outstanding achievement for the advance of health care. There are hopes for similar results with an artificial heart. Many serious questions, both technical and...
3.
Reiff A, Zastrow M, Sun B, Takei S, Mitsuhada H, Bernstein B, et al.
Clin Exp Rheumatol
. 2002 Jan;
19(6):639-46.
PMID: 11791634
Objective: To evaluate the safety and efficacy of L-asparaginase as an immunosuppressive agent in a mouse model of rheumatoid arthritis. Methods: Male DBA/1 mice with collagen-induced arthritis (CIA) were treated...
4.
Barba C, Taggert J, Morgan A, Guerra J, Bernstein B, Lorenzo M, et al.
J Trauma
. 2001 Oct;
51(4):652-6; discussion 656-7.
PMID: 11586154
Objective: The purpose of this study was to assess a cervical spine clearance protocol for blunt trauma patients using helical computed tomographic (CT) scan of the cervical spine (C-spine). Methods:...
5.
Takei S, Groh D, Bernstein B, Shaham B, Gallagher K, Reiff A
J Rheumatol
. 2001 Jul;
28(7):1677-80.
PMID: 11469478
Objective: To evaluate safety and efficacy of high dose etanercept (> 0.8 mg/kg, maximum 25 mg subcutaneously twice weekly) (Enbrel) in children with juvenile rheumatoid arthritis (JRA) and inadequate prior...
6.
Reiff A, Takei S, Sadeghi S, Stout A, Shaham B, Bernstein B, et al.
Arthritis Rheum
. 2001 Jun;
44(6):1411-5.
PMID: 11407702
Objective: To evaluate the safety and efficacy of the tumor necrosis factor fusion protein etanercept in children with treatment-resistant uveitis. Methods: Ten children with chronic active uveitis (7 girls and...
7.
Gallagher K, Shaham B, Reiff A, Tournay A, Villablanca J, Curran J, et al.
J Rheumatol
. 2001 Apr;
28(3):616-23.
PMID: 11296969
We describe 5 children who meet criteria for primary angiitis of the central nervous system (PACNS). All patients presented with headache and/or focal neurologic deficits and exhibited clinical and/or radiographic...
8.
Perez-Escamilla R, Ferris A, Drake L, Haldeman L, Peranick J, Campbell M, et al.
J Nutr
. 2000 Oct;
130(11):2711-7.
PMID: 11053511
The goal of the present study was to examine the association of the Food Stamp Program with the food security and dietary intake of low-income children from Hartford, CT, who...
9.
Mofid M, Costarangos C, Bernstein B, Wong L, Munster A, Nousari H
J Burn Care Rehabil
. 2000 Jun;
21(3):246-7.
PMID: 10850906
Drug-induced linear immunoglobulin A bullous disease is a subepidermal blistering disorder that most commonly occurs after exposure to vancomycin. It can clinically mimic toxic epidermolytic necrolysis. We describe an 87-year-old...
10.
Gallagher K, Bernstein B
Curr Opin Rheumatol
. 1999 Sep;
11(5):372-6.
PMID: 10503657
The heterogeneous nature of juvenile rheumatoid arthritis is further defined in publications from the past year. Decreased IL-10 production, an anti-inflammatory cytokine, and soluble IL-6 receptor are associated with systemic...